2023-09-012024-08-312024-08-31false08649020LARGE ATTALE MEDICAL LTD2025-02-18falseiso4217:GBPxbrli:pure086490202023-09-01086490202024-08-31086490202023-09-012024-08-31086490202022-09-01086490202023-08-31086490202022-09-012023-08-3108649020bus:SmallEntities2023-09-012024-08-3108649020bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3108649020bus:FullAccounts2023-09-012024-08-3108649020bus:PrivateLimitedCompanyLtd2023-09-012024-08-3108649020core:WithinOneYear2024-08-3108649020core:AfterOneYear2024-08-3108649020core:WithinOneYear2023-08-3108649020core:AfterOneYear2023-08-3108649020core:ShareCapital2024-08-3108649020core:SharePremium2024-08-3108649020core:RevaluationReserve2024-08-3108649020core:OtherReservesSubtotal2024-08-3108649020core:RetainedEarningsAccumulatedLosses2024-08-3108649020core:ShareCapital2023-08-3108649020core:SharePremium2023-08-3108649020core:RevaluationReserve2023-08-3108649020core:OtherReservesSubtotal2023-08-3108649020core:RetainedEarningsAccumulatedLosses2023-08-3108649020core:LandBuildings2024-08-3108649020core:PlantMachinery2024-08-3108649020core:Vehicles2024-08-3108649020core:FurnitureFittings2024-08-3108649020core:OfficeEquipment2024-08-3108649020core:NetGoodwill2024-08-3108649020core:IntangibleAssetsOtherThanGoodwill2024-08-3108649020core:ListedExchangeTraded2024-08-3108649020core:UnlistedNon-exchangeTraded2024-08-3108649020core:LandBuildings2023-08-3108649020core:PlantMachinery2023-08-3108649020core:Vehicles2023-08-3108649020core:FurnitureFittings2023-08-3108649020core:OfficeEquipment2023-08-3108649020core:NetGoodwill2023-08-3108649020core:IntangibleAssetsOtherThanGoodwill2023-08-3108649020core:ListedExchangeTraded2023-08-3108649020core:UnlistedNon-exchangeTraded2023-08-3108649020core:LandBuildings2023-09-012024-08-3108649020core:PlantMachinery2023-09-012024-08-3108649020core:Vehicles2023-09-012024-08-3108649020core:FurnitureFittings2023-09-012024-08-3108649020core:OfficeEquipment2023-09-012024-08-3108649020core:NetGoodwill2023-09-012024-08-3108649020core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3108649020core:ListedExchangeTraded2023-09-012024-08-3108649020core:UnlistedNon-exchangeTraded2023-09-012024-08-3108649020core:MoreThanFiveYears2023-09-012024-08-3108649020core:Non-currentFinancialInstruments2024-08-3108649020core:Non-currentFinancialInstruments2023-08-3108649020dpl:CostSales2023-09-012024-08-3108649020dpl:DistributionCosts2023-09-012024-08-3108649020core:LandBuildings2023-09-012024-08-3108649020core:PlantMachinery2023-09-012024-08-3108649020core:Vehicles2023-09-012024-08-3108649020core:FurnitureFittings2023-09-012024-08-3108649020core:OfficeEquipment2023-09-012024-08-3108649020dpl:AdministrativeExpenses2023-09-012024-08-3108649020core:NetGoodwill2023-09-012024-08-3108649020core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3108649020dpl:GroupUndertakings2023-09-012024-08-3108649020dpl:ParticipatingInterests2023-09-012024-08-3108649020dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3108649020core:ListedExchangeTraded2023-09-012024-08-3108649020dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3108649020core:UnlistedNon-exchangeTraded2023-09-012024-08-3108649020dpl:CostSales2022-09-012023-08-3108649020dpl:DistributionCosts2022-09-012023-08-3108649020core:LandBuildings2022-09-012023-08-3108649020core:PlantMachinery2022-09-012023-08-3108649020core:Vehicles2022-09-012023-08-3108649020core:FurnitureFittings2022-09-012023-08-3108649020core:OfficeEquipment2022-09-012023-08-3108649020dpl:AdministrativeExpenses2022-09-012023-08-3108649020core:NetGoodwill2022-09-012023-08-3108649020core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3108649020dpl:GroupUndertakings2022-09-012023-08-3108649020dpl:ParticipatingInterests2022-09-012023-08-3108649020dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3108649020core:ListedExchangeTraded2022-09-012023-08-3108649020dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3108649020core:UnlistedNon-exchangeTraded2022-09-012023-08-3108649020core:NetGoodwill2024-08-3108649020core:IntangibleAssetsOtherThanGoodwill2024-08-3108649020core:LandBuildings2024-08-3108649020core:PlantMachinery2024-08-3108649020core:Vehicles2024-08-3108649020core:FurnitureFittings2024-08-3108649020core:OfficeEquipment2024-08-3108649020core:AfterOneYear2024-08-3108649020core:WithinOneYear2024-08-3108649020core:ListedExchangeTraded2024-08-3108649020core:UnlistedNon-exchangeTraded2024-08-3108649020core:ShareCapital2024-08-3108649020core:SharePremium2024-08-3108649020core:RevaluationReserve2024-08-3108649020core:OtherReservesSubtotal2024-08-3108649020core:RetainedEarningsAccumulatedLosses2024-08-3108649020core:NetGoodwill2023-08-3108649020core:IntangibleAssetsOtherThanGoodwill2023-08-3108649020core:LandBuildings2023-08-3108649020core:PlantMachinery2023-08-3108649020core:Vehicles2023-08-3108649020core:FurnitureFittings2023-08-3108649020core:OfficeEquipment2023-08-3108649020core:AfterOneYear2023-08-3108649020core:WithinOneYear2023-08-3108649020core:ListedExchangeTraded2023-08-3108649020core:UnlistedNon-exchangeTraded2023-08-3108649020core:ShareCapital2023-08-3108649020core:SharePremium2023-08-3108649020core:RevaluationReserve2023-08-3108649020core:OtherReservesSubtotal2023-08-3108649020core:RetainedEarningsAccumulatedLosses2023-08-3108649020core:NetGoodwill2022-09-0108649020core:IntangibleAssetsOtherThanGoodwill2022-09-0108649020core:LandBuildings2022-09-0108649020core:PlantMachinery2022-09-0108649020core:Vehicles2022-09-0108649020core:FurnitureFittings2022-09-0108649020core:OfficeEquipment2022-09-0108649020core:AfterOneYear2022-09-0108649020core:WithinOneYear2022-09-0108649020core:ListedExchangeTraded2022-09-0108649020core:UnlistedNon-exchangeTraded2022-09-0108649020core:ShareCapital2022-09-0108649020core:SharePremium2022-09-0108649020core:RevaluationReserve2022-09-0108649020core:OtherReservesSubtotal2022-09-0108649020core:RetainedEarningsAccumulatedLosses2022-09-0108649020core:AfterOneYear2023-09-012024-08-3108649020core:WithinOneYear2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3108649020core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3108649020core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3108649020core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3108649020core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3108649020core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3108649020core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3108649020core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3108649020core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3108649020core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3108649020core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3108649020core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3108649020bus:Director12023-09-012024-08-3108649020bus:Director22023-09-012024-08-31

LARGE ATTALE MEDICAL LTD

Registered Number
08649020
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

LARGE ATTALE MEDICAL LTD
Company Information
for the year from 1 September 2023 to 31 August 2024

Directors

ATTALE, Shanika Rukmali Abeyratna, Dr
LARGE, Oliver Drury Helliwell, Dr

Registered Address

8 Grange Road
Hazlemere
High Wycombe
HP15 7QZ

Registered Number

08649020 (England and Wales)
LARGE ATTALE MEDICAL LTD
Balance Sheet as at
31 August 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3376494
376494
Current assets
Debtors4-18,580
Cash at bank and on hand6,42348,800
6,42367,380
Creditors amounts falling due within one year5(3,046)(57,245)
Net current assets (liabilities)3,37710,135
Total assets less current liabilities3,75310,629
Provisions for liabilities6(71)(94)
Net assets3,68210,535
Capital and reserves
Called up share capital100100
Profit and loss account3,58210,435
Shareholders' funds3,68210,535
The financial statements were approved and authorised for issue by the Board of Directors on 18 February 2025, and are signed on its behalf by:
LARGE, Oliver Drury Helliwell, Dr
Director
Registered Company No. 08649020
LARGE ATTALE MEDICAL LTD
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
2.Average number of employees

20242023
Average number of employees during the year00
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 September 231412,5332,674
At 31 August 241412,5332,674
Depreciation and impairment
At 01 September 23882,0922,180
Charge for year118-118
At 31 August 242062,0922,298
Net book value
At 31 August 24(65)441376
At 31 August 2353441494
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables-1,100
Other debtors-17,480
Total-18,580
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security-9,440
Other creditors1,90646,006
Accrued liabilities and deferred income1,1401,799
Total3,04657,245
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)7194
Total7194
7.Directors advances, credits and guarantees
The director's current account credit balance of £1,906 (2023: £46,006) relates to Dr Oliver Large Dr Shanika Attale.